Bionano Genomics, Inc. — Director's Dealing 2020

May 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2020-05-04

Reporting Person: Mamuszka Hannah (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-04	Stock Option (right to buy)	$0.38	A	80923	Acquired	2030-05-04	Common Stock (80923)	Direct

Footnotes

F1: The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).